Within the tumor microenvironment, TGF-β is the most potent suppressor of radiotherapy-triggered anti-tumor T-cell responses (Vanpouille-Box et al., 2015; Wennerberg et al., 2017; Farhood et al., 2020; Liu et al., 2021). The gene discussed is TGFB1; the disease is neoplasm.